Global Cord Blood Corporation Share Price Börse Stuttgart
Equities
6CB
KYG393421030
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.96 EUR | +1.02% | +4.21% | +38.46% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M 148M 13.36B | Sales 2022 | 1.24B 172M 159M 14.32B | Capitalization | 2.97B 410M 379M 34.2B |
---|---|---|---|---|---|
Net income 2021 | 508M 70.1M 64.9M 5.85B | Net income 2022 | 501M 69.13M 64.01M 5.77B | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 838M 776M 69.98B | Net cash position 2022 | 6.66B 919M 851M 76.75B | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
1 week | +4.21% | ||
1 month | +2.06% | ||
3 months | -9.59% | ||
6 months | +2.06% | ||
Current year | +38.46% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01/09/01 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01/04/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01/09/01 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01/09/01 |
Director/Board Member | 56 | 01/09/01 |
1st Jan change | Capi. | |
---|---|---|
+24.66% | 88.38B | |
-21.76% | 77.56B | |
+5.70% | 26.97B | |
-13.50% | 16.57B | |
+3.23% | 15.81B | |
+77.51% | 13.65B | |
+76.96% | 13.06B | |
+4.72% | 12.61B | |
+36.67% | 12.56B |
- Stock Market
- Equities
- CORBF Stock
- 6CB Stock